Dietary effects of mead acid on n-methyl-n-nitrosourea-induced mammary cancers in female sprague-dawley rats

Biomedical Reports

Volumn 4, Issue 1, 2016, Pages 33-39

  Kinoshita, Yuichi ^a,b   Yoshizawa, Katsuhiko ^a   Hamazaki, Kei ^c   Emoto, Yuko ^a   Yuri, Takashi ^a   Yuki, Michiko ^a   Kawashima, Hiroshi ^d   Shikata, Nobuaki ^b   Tsubura, Airo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY MEDICAL CENTER   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

^d Suntory Wellness Limited Research Center   (Japan)

Author keywords

Intrinsic subtype; Luminal A; Mammary cancer; Mead acid; N methyl N nitrosourea

Indexed keywords

5,8,11 ICOSATRIENOIC ACID; METHYLNITROSOUREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER INCIDENCE; CELL KINETICS; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; IMMUNOHISTOCHEMISTRY; LIPID COMPOSITION; MICROVASCULATURE; NONHUMAN; NUTRITIONAL ASSESSMENT; RAT;

EID: 84962960646     PISSN: 20499434     EISSN: 20499442     Source Type: Journal    
DOI: 10.3892/br.2015.530     Document Type: Article

References (31)

1. Freedman LS, Kipnis V, Schatzkin A and Potischman N: Methods of epidemiology: Evaluating the fat-breast cancer hypothesis-comparing dietary instruments and other developments. Cancer J 14: 69-74, 2002.
2. Yang B, Ren XL, Fu YQ, Gao JL and Li D: Ratio of n-3/n-6 PUFAs and risk of breast cancer: A meta-analysis of 274135 adult females from 11 independent prospective studies. BMC Cancer 14: 105, 2014.
3. Takata T, Minoura T, Takada H, Sakaguchi M, Yamamura M, Hioki K and Yamamoto M: Specific inhibitory effect of dietary eicosapentaenoic acid on N-nitroso-N-methylurea-induced mammary carcinogenesis in female Sprague-Dawley rats. Carcinogenesis 11: 2015-2019, 1990.
4. Yuri T, Danbara N, Tsujita-Kyutoku M, Fukunaga K, Takada H, Inoue Y, Hada T and Tsubura A: Dietary docosahexaenoic acid suppresses N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats more effectively than eicosapentaenoic acid. Nutr Cancer 45: 211-217, 2003.
5. Cohen LA, Thompson DO, Maeura Y, Choi K, Blank ME and Rose DP: Dietary fat and mammary cancer. I. Promoting effects of different dietary fats on N-nitrosomethylurea-induced rat mammary tumorigenesis. J Natl Cancer Inst 77: 33-42, 1986.
6. Zhu Z, Jiang W, McGinley JN, Prokopczyk B, Richie JP Jr, El Bayoumy K, Manni A and Thompson HJ: Mammary gland density predicts the cancer inhibitory activity of the N-3 to N-6 ratio of dietary fat. Cancer Prev Res (Phila) 4: 1675-1685, 2011.
7. Senzaki H, Iwamoto S, Ogura E, Kiyozuka Y, Arita S, Kurebayashi J, Takada H, Hioki K and Tsubura A: Dietary effects of fatty acids on growth and metastasis of KPL-1 human breast cancer cells in vivo and in vitro. Anticancer Res 18: 1621-1627, 1998.
8. Chang NW, Wu CT, Chen DR, Yeh CY and Lin C: High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation. J Nutr Biochem 24: 274-281, 2013.
9. Trichopoulou A, Lagiou P, Kuper H and Trichopoulos D: Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev 9: 869-873, 2000.
10. Buckland G, Travier N, Agudo A, Fonseca-Nunes A, Navarro C, Lagiou P, Demetriou C, Amiano P, Dorronsoro M, Chirlaque MD, et al: Olive oil intake and breast cancer risk in the Mediterranean countries of the European prospective investigation into cancer and nutrition study. Int J Cancer 131: 2465-2469, 2012.
11. Rose DP and Connolly JM: Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res 50: 7139-7144, 1990.
12. Fulco AJ and Mead JF: Metabolism of essential fatty acids. VIII. Origin of 5,8,11-eicosatrienoic acid in the fat-deficient rat. J Biol Chem 234: 1411-1416, 1959.
13. Ichi I, Kono N, Arita Y, Haga S, Arisawa K, Yamano M, Nagase M, Fujiwara Y and Arai H: Identification of genes and pathways involved in the synthesis of Mead acid (20:3 n-9), an indicator of essential fatty acid deficiency. Biochim Biophys Acta 1841: 204-213, 2014.
14. Pouchieu C, Chajès V, Laporte F, Kesse-Guyot E, Galan P, Hercberg S, Latino-Martel P and Touvier M: Prospective associations between plasma saturated, monounsaturated and polyunsaturated fatty acids and overall and breast cancer risk-modulation by antioxidants: A nested case-control study. PLoS One 9: e90442, 2014.
15. Heyd VL and Eynard AR: Effects of eicosatrienoic acid (20:3 n-9, Mead's acid) on some promalignant-related properties of three human cancer cell lines. Prostaglandins Other Lipid Mediat 71: 177-188, 2003.
16. Kinoshita Y, Yoshizawa K, Hamazaki K, Emoto Y, Yuri T, Yuki M, Shikata N, Kawashima H and Tsubura A: Mead acid inhibits the growth of KPL-1 human breast cancer cells in vitro and in vivo. Oncol Rep 32: 1385-1394, 2014.
17. Kurebayashi J, Kanomata N, Moriya T, Kozuka Y, Watanabe M and Sonoo H: Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype. BMC Cancer 10: 568, 2010.
18. Sandhu R, Parker JS, Jones WD, Livas CA and Coleman WB: Microarray-based profiling for molecular classification of breast cancer and identification of new targets for therapy. Lab Medicine, 41: 364-372, 2010.
19. Sakuradani E, Kamada N, Hirano Y, Nishihara M, Kawashima H, Akimoto K, Higashiyama K, Ogawa J and Shimizu S: Production of 5,8,11-eicosatrienoic acid by a delta5 and delta6 desaturation activity-enhanced mutant derived from a delta12 desaturation activity-defective mutant of Mortierella alpina 1S-4. Appl Microbiol Biotechnol 60: 281-287, 2002.
20. Kanematsu S, Yoshizawa K, Uehara N, Miki H, Sasaki T, Kuro M, Lai YC, Kimura A, Yuri T and Tsubura A: Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice. Oncol Rep 26: 603-608, 2011.
21. Redon CE, Weyemi U, Parekh PR, Huang D, Burrell AS and Bonner WM: γ-H2AX and other histone post-translational modifications in the clinic. Biochim Biophys Acta 1819: 743-756, 2012.
22. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, et al: American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28: 2784-2795, 2010.
23. Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, et al: Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology/college of American pathologists clinical practice guideline update. J Clin Oncol 31: 3997-4013, 2013.
24. Russo J: Significance of rat mammary tumors for human risk assessment. Toxicol Pathol 4: 145-170, 2015.
25. Bligh EG and Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
26. Tsubura A, Uehara N, Kiyozuka Y and Shikata N: Dietary factors modifying breast cancer risk and relation to time of intake. J Mammary Gland Biol Neoplasia 10: 87-100, 2005.
27. Cazzaniga M and Bonanni B: Breast cancer chemoprevention: Old and new approaches. J Biomed Biotechnol 2012: 985620, 2012.
28. Hamazaki T, Nagasawa T, Hamazaki K and Itomura M: Inhibitory effect of 5,8,11-eicosatrienoic acid on angiogenesis. Prostaglandins Leukot Essent Fatty Acids 86: 221-224, 2012.
29. Okuyama H, Kobayashi T and Watanabe S: Dietary fatty acids-the N-6/N-3 balance and chronic elderly diseases. Excess linoleic acid and relative N-3 deficiency syndrome seen in Japan. Prog Lipid Res 35: 409-457, 1996.
30. Lips EH, Mulder L, de Ronde JJ, Mandjes IA, Koolen BB, Wessels LF, Rodenhuis S and Wesseling J: Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response. Breast Cancer Res Treat 140: 63-71, 2013.
31. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B and Senn HJ; Panel members: Strategies for subtypes-dealing with the diversity of breast cancer: Highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol 22: 1736-1747, 2011.